HIV-infected patients diagnosed with cryptococcal meningitis who received antiretroviral therapy (ART) 5 weeks after starting antifungal therapy had improved survival at 26 weeks compared to similar patients who received ART at 1-2 weeks (45% vs 30%, respectively, P=0.03).
HIV-infected patients diagnosed with cryptococcal meningitis who received antiretroviral therapy (ART) 5 weeks after starting antifungal therapy had improved survival at 26 weeks compared to similar patients who received ART at 1-2 weeks (45% vs 30%, respectively, P=0.03).
Delaying Initiation of Antiretroviral Therapy for Cryptococcal Meningitis Improves Survival
September 1, 2014